FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Authors:
- Linda VignozziLVLinda Vignozzi
- Annamaria MorelliAnnamaria Morelli
- Tommaso MelloTMTommaso Mello
- Erica SarchielliESErica Sarchielli
- Roberto VettorRVRoberto Vettor
- Gabriella Barbara VannelliGVGabriella Barbara Vannelli
- 7 June 2013
- journal article
- Published by Bioscientifica in Journal of Endocrinology
- Vol. 218 (2) , 215-231
Abstract
Insulin resistance is the putative key underlying mechanism linking adipose tissue (AT) dysfunction with liver inflammation and steatosis in metabolic syndrome (MetS). We have recently demonstrated that the selective farnesoid X receptor (FXR) agonist obeticholic acid (OCA) ameliorates insulin resistance and the metabolic profile with a marked reduction in the amount of visceral AT (VAT) in a high-fat diet (HFD)-induced rabbit model of MetS. These effects were mediated by the activation of FXR, since treatment with the selective TGR5 agonist INT-777 was not able to ameliorate the metabolic parameters evaluated. Herein, we report the effects ofin vivoOCA dosing on the liver, the VAT, and the adipogenic capacity of VAT preadipocytes (rPADs) isolated from rabbits on a HFD compared with those on a control diet. VAT and liver were studied by immunohistochemistry, Western blot analysis, and RT-PCR. rPADs were exposed to a differentiating mixture to evaluate adipogenesis. Adipocyte size, hypoxia, and the expression of perilipin and cytosolic insulin-regulated glucose transporter GLUT4 (SLC2A4) were significantly increased in VAT isolated from the HFD rabbits, and normalized by OCA. The expression of steatosis and inflammation markers was increased in the liver of the HFD rabbits and normalized by OCA. rPADs isolated from the HFD rabbits were less sensitive to insulin, as demonstrated by the decreased insulin-induced glucose uptake, triglyceride synthesis, and adipogenic capacity, as well as by the impaired fusion of lipid droplets. OCA treatment preserved all the aforementioned metabolic functions. In conclusion, OCA dosing in a MetS rabbit model ameliorates liver and VAT functions. This could reflect the ability of OCA to restore insulin sensitivity in AT unable to finalize its storage function, counteracting MetS-induced metabolic alterations and pathological AT deposition.Keywords
This publication has 48 references indexed in Scilit:
- Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome‐associated prostate alterations: An experimental study in the rabbitThe Prostate, 2012
- Hypoxia-induced inflammatory cytokine secretion in human adipose tissue stromovascular cellsDiabetologia, 2011
- Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and DiabetesThe Journal of Sexual Medicine, 2011
- Functional Characterization of the Semisynthetic Bile Acid Derivative INT-767, a Dual Farnesoid X Receptor and TGR5 AgonistMolecular Pharmacology, 2010
- FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese ratsJournal of Lipid Research, 2010
- Harmonizing the Metabolic SyndromeCirculation, 2009
- TGR5-Mediated Bile Acid Sensing Controls Glucose HomeostasisCell Metabolism, 2009
- Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaeaBiochemical and Biophysical Research Communications, 2007
- Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineagesProceedings of the National Academy of Sciences, 2007
- Abdominal obesity and metabolic syndromeNature, 2006